NO323880B1 - Anvendelse av et lektin ved fremstilling av et medikament for reduksjon og/eller behandling av skade pa mukosaceller og/eller -vev - Google Patents

Anvendelse av et lektin ved fremstilling av et medikament for reduksjon og/eller behandling av skade pa mukosaceller og/eller -vev Download PDF

Info

Publication number
NO323880B1
NO323880B1 NO19985980A NO985980A NO323880B1 NO 323880 B1 NO323880 B1 NO 323880B1 NO 19985980 A NO19985980 A NO 19985980A NO 985980 A NO985980 A NO 985980A NO 323880 B1 NO323880 B1 NO 323880B1
Authority
NO
Norway
Prior art keywords
lectin
treatment
growth factor
pha
tissue
Prior art date
Application number
NO19985980A
Other languages
English (en)
Norwegian (no)
Other versions
NO985980D0 (no
NO985980L (no
Inventor
Arpad Janos Pusztai
Zsuszanna Magdolna Bardocz
Richard Michael John Palmer
Neil William Fish
Gyorgy Koteles
Original Assignee
Alizyme Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10795697&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO323880(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Alizyme Therapeutics Ltd filed Critical Alizyme Therapeutics Ltd
Publication of NO985980D0 publication Critical patent/NO985980D0/no
Publication of NO985980L publication Critical patent/NO985980L/no
Publication of NO323880B1 publication Critical patent/NO323880B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/168—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/185—Vegetable proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8962—Allium, e.g. garden onion, leek, garlic or chives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Polymers & Plastics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Obesity (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
NO19985980A 1996-06-21 1998-12-18 Anvendelse av et lektin ved fremstilling av et medikament for reduksjon og/eller behandling av skade pa mukosaceller og/eller -vev NO323880B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9613070.3A GB9613070D0 (en) 1996-06-21 1996-06-21 Dietary lectins
PCT/GB1997/001668 WO1997049420A1 (en) 1996-06-21 1997-06-20 Lectin compositions and uses thereof

Publications (3)

Publication Number Publication Date
NO985980D0 NO985980D0 (no) 1998-12-18
NO985980L NO985980L (no) 1999-02-19
NO323880B1 true NO323880B1 (no) 2007-07-16

Family

ID=10795697

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19985980A NO323880B1 (no) 1996-06-21 1998-12-18 Anvendelse av et lektin ved fremstilling av et medikament for reduksjon og/eller behandling av skade pa mukosaceller og/eller -vev

Country Status (16)

Country Link
EP (1) EP0942741B1 (de)
JP (1) JP4379924B2 (de)
CN (1) CN1157225C (de)
AT (1) ATE229341T1 (de)
AU (1) AU738386B2 (de)
CA (1) CA2258503C (de)
DE (1) DE69717849T2 (de)
DK (1) DK0942741T3 (de)
ES (1) ES2190535T3 (de)
GB (1) GB9613070D0 (de)
NO (1) NO323880B1 (de)
NZ (1) NZ333411A (de)
PL (1) PL190301B1 (de)
PT (1) PT942741E (de)
RU (1) RU2202361C2 (de)
WO (1) WO1997049420A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020132017A1 (en) 1996-12-09 2002-09-19 Moore Jeffrey G. Composition and method for preserving progenitor cells
US6991794B1 (en) 1997-06-24 2006-01-31 Imclone Systems Incorporated Progenitor cell preservation factors and methods for and products of their use
US6310195B1 (en) 1997-06-24 2001-10-30 Imclone Systems Incorporated Nucleic acid encoding a lectin-derived progenitor cell preservation factor
US20020169128A1 (en) * 2001-04-09 2002-11-14 Geroge Sigounas Erythropoietin ameliorates chemotherapy-induced toxicity in vivo
KR100473422B1 (ko) * 2003-06-12 2005-03-14 박원봉 렉틴 함유 천연물의 장용성 코팅용 조성물
PL375746A1 (pl) * 2005-06-16 2006-12-27 Biolek Sp Z Oo Sposób otrzymywania preparatu lektynowego, preparat lektynowy oraz sposób podawania preparatu lektynowego dla ssaków
ATE539622T1 (de) 2008-04-02 2012-01-15 Helvista Ag Verwendung einer zusammensetzung, welche ein pflanzenlektin, ein proteolytisches enzym und eine selenverbindung umfasst, zum schleimhautschutz und zur linderung anderer symptome bei krebspatienten
DE502009000459D1 (de) 2009-02-10 2011-04-28 Helvista Ag Lektinzusammensetzung zur Prophylaxe und/oder Behandlung von unerwünschten Arzneimittelnebenwirkungen
DE102010033458B4 (de) * 2010-08-05 2016-03-10 Helvista Ag Emulgierte Lektinzusammensetzungen und ihre Verwendung
CN103068263A (zh) * 2010-08-12 2013-04-24 百奥莱克有限公司 从普通豆类提取凝集素的方法以及凝集素制剂
US10245255B2 (en) 2011-02-14 2019-04-02 The Regents Of The University Of Michigan Compositions and methods for the treatment of obesity and related disorders
WO2014179734A1 (en) 2013-05-02 2014-11-06 The Regents Of The University Of Michigan Deuterated amlexanox
US10214536B2 (en) 2016-01-29 2019-02-26 The Regents Of The University Of Michigan Amlexanox analogs
EP3243523B1 (de) 2016-05-11 2020-04-29 YACARE GmbH Lektine und krebsprophylaxe
US10918695B2 (en) 2019-01-03 2021-02-16 The Secretary, Department Of Atomic Energy Use of jack bean lectin for increasing the abundance of hematopoietic stem cells and progenitor cells in bone marrow and/or epidermal stem cells in skin in vivo
EP3701967B1 (de) 2019-02-26 2025-07-30 The Secretary, Department Of Atomic Energy Verwendung von schwertbohnenlectin zur erhöhung der menge hämatopoietischer stammzellen und vorläuferzellen in knochenmark und/oder epidermaler stammzellen in der haut in vivo
GB201903244D0 (en) 2019-03-14 2019-04-24 Syndermix Ag Methods for lectin production with improved yield
CN110433280A (zh) * 2019-09-11 2019-11-12 周口师范学院 植物血凝素在制备预防或治疗肥胖药物中的应用
CN112707958B (zh) * 2020-12-26 2023-08-29 郑州伊美诺生物技术有限公司 一种提取l型和e型植物凝集素的方法
EP4395806B1 (de) * 2021-08-30 2025-10-22 Unichem Laboratories Ltd Proteinzusammensetzungen zur behandlung von oraler mukositis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5053386A (en) * 1987-07-24 1991-10-01 Tung Ta C Orally administrable anti-metastatic lectin compositions and methods
DE4318307A1 (de) * 1993-06-02 1994-12-08 Ludwig Dr Rer Nat Habil Jonas Einsatz von Lektinen zur Therapie der akuten und chronischen Pankreatitis des Menschen

Also Published As

Publication number Publication date
WO1997049420A1 (en) 1997-12-31
PT942741E (pt) 2003-04-30
CN1157225C (zh) 2004-07-14
NZ333411A (en) 2000-08-25
JP4379924B2 (ja) 2009-12-09
CA2258503C (en) 2009-08-11
DE69717849D1 (de) 2003-01-23
CN1230891A (zh) 1999-10-06
EP0942741A1 (de) 1999-09-22
NO985980D0 (no) 1998-12-18
PL190301B1 (pl) 2005-11-30
RU2202361C2 (ru) 2003-04-20
PL330865A1 (en) 1999-06-07
NO985980L (no) 1999-02-19
GB9613070D0 (en) 1996-08-28
JP2001510447A (ja) 2001-07-31
AU738386B2 (en) 2001-09-20
AU3183297A (en) 1998-01-14
ES2190535T3 (es) 2003-08-01
ATE229341T1 (de) 2002-12-15
DE69717849T2 (de) 2003-11-13
CA2258503A1 (en) 1997-12-31
EP0942741B1 (de) 2002-12-11
DK0942741T3 (da) 2003-04-07

Similar Documents

Publication Publication Date Title
NO323880B1 (no) Anvendelse av et lektin ved fremstilling av et medikament for reduksjon og/eller behandling av skade pa mukosaceller og/eller -vev
KR100605292B1 (ko) 신규한 오가피 및 오가피 열매, 가시오가피 다당체, 그제조방법 및 그를 활성성분으로 함유하는 항암제 조성물
Mayell Maitake extracts and their therapeutic potential-a review
Chauhan A pilot study on wheat grass juice for its phytochemical, nutritional and therapeutic potential on chronic diseases
US6110891A (en) Lectin compositions and uses thereof
Bertollo et al. Agaricus blazei Murrill mushroom: A review on the prevention and treatment of cancer
Wang et al. Aloe polysaccharides mediated radioprotective effect through the inhibition of apoptosis
WO2006116452A1 (en) Nutritional composition comprising hyaluronic acid and superoxide dismutase and methods of making and using same
Sumaina et al. Tahini: The magical condiment
Javed et al. Functional Food Industry
Razak Abood Alsaadi Assessing the Antioxidant Potential of Ginger Aqueous Extract on H2O2 Induced Oxidative Stress in Local Rabbits: A Comprehensive Study of Hematological Parameters.
KR101642176B1 (ko) 성장촉진 조성물
CN105796608A (zh) 复方富勒烯保健饮用水及其制备方法
CN109731019B (zh) 一种具有化疗增效作用的组合物，包括组成、制备及应用
El-Bolkiny et al. Ameliorating effects of rosemary and costus on blood-associated toxicity in Ehrlich-bearing mice treated with cisplatin
KR100518126B1 (ko) 렉틴조성물및이의용도
Aminin et al. Radioprotective properties of cumaside, a complex of triterpene glycosides from the sea cucumber Cucumaria japonica and cholesterol
Orsolic et al. Antimetastatic effect of honey.
Rastogi et al. Pycnogenol: the hercules of antioxidants
US10532075B2 (en) Use of a particular extract of propolis for combating the side effects of chemotherapy
KR20150104950A (ko) 헤스페레틴 또는 이의 약학적으로 허용가능한 염을 유효성분으로 함유하는 방사선에 의한 세포 또는 조직 손상 예방 및 치료용 약학적 조성물
Talih et al. Effect of lingzhi or reishi medicinal mushroom, Ganoderma lucidum (Agaricomycetes), capsules on colistin-induced nephrotoxicity
Senapathy et al. Chemoprotective and Immunomodulating Effects of Ferulic Acid on Cisplatin Chemotherapy in Dalton’s Lymphoma Xenografted Mice
Nkono et al. Free Radical Scavenging Activity of Cymbopogon Citratus (Stapf) and Evaluation of its Antiproliferative Effect on MG-63 Human Osteosarcoma Cells
Elkins Pycnogenol

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees